Skip to content
stoqly

Constellium Se

CSTM NYSE Secondary Smelting & Refining Of Nonferrous Metals Financials FY2022–FY2025

Revenue Total sales reported in the income statement.
$8.4B
15.2% vs prior year
Operating margin Operating income as a share of revenue.
β€”
Net income Profit after all expenses, interest and tax.
$273M
387.5%
Free cash flow Cash from operations minus capital spending.
$159M
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
β€”
Market cap Last close times the latest diluted share count, so it is approximate.
β€”
P/E Last close divided by diluted earnings per share over the last four quarters.
β€”
On $3.08 EPS (TTM)

What Constellium Se does

No business description yet.

Legal name
CONSTELLIUM SE
Fiscal year ends
December 31, 2025
Latest annual report
10-K Β· Feb 25, 2026
Accession Β· CIK
0001563411-26-000057
0001563411

Revenue and margins

Constellium Se had $8.4B of revenue in fiscal 2025, up 15.2% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

From fiscal 2022 to 2025, diluted EPS grew βˆ’2.9% a year. Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $159M in fiscal 2025, 1.9% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Constellium Se returned $115M to shareholders in fiscal 2025, 72% of free cash flow. The diluted share count fell 4.1%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Balance sheet

Cash, debt and the ratios that show how comfortably Constellium Se can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY22FY23FY24FY25
Cash and short-term investments $176M$223M$141M$120M
Debt incl. finance leases β€”$2.0B$1.9B$2.0B
Debt / equity β€”2.7x2.7x2.0x
Current ratio β€”1.3x1.3x1.3x
Quick ratio β€”0.5x0.5x0.5x
Total assets β€”$4.9B$4.7B$5.4B
Total liabilities β€”$4.2B$4.0B$4.4B
Shareholders' equity $603M$718M$706M$952M
Net debt (βˆ’ = net cash) β€”$1.7B$1.8B$1.9B

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$0.0M

0 insiders

Of sales under plans

β€”

$0.0M

No open-market insider trades in the last 12 months.

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY22FY23FY24FY25
Net income is positive βœ“ βœ“ βœ“ βœ“
Cash from operations is positive βœ“ βœ“ βœ“ βœ“
Return on assets rose β€” β€” βœ• βœ“
Cash from operations exceeds net income βœ“ βœ“ βœ“ βœ“
Debt fell relative to assets β€” β€” βœ• βœ“
Current ratio rose β€” β€” βœ• βœ“
Share count didn't rise β€” βœ• βœ“ βœ“
Gross margin rose β€” β€” β€” β€”
Revenue rose relative to assets β€” β€” βœ• βœ“
F-score β€” / 3β€” / 44 / 88 / 8
Accruals ratio β€”βˆ’5.7%βˆ’5.1%βˆ’4.3%
Altman Z'' β€”β€”β€”β€”

4 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY22FY23FY24FY25
Income statement
Revenue $8.5B $7.8B $7.3B $8.4B
Research and development $46.0M $52.0M $49.0M $51.0M
Interest expense $96.0M $101M $99.0M $102M
Pretax income $150M $232M $135M $408M
Income tax βˆ’$165M $75.0M $75.0M $133M
Net income $308M $152M $56.0M $273M
Diluted EPS $2.10 $1.03 $0.38 $1.92
Diluted shares 0.15B 0.15B 0.15B 0.14B
Cash flow
Cash from operations $365M $432M $301M $489M
Capital expenditure $289M $366M $413M $330M
Free cash flow $76.0M $66.0M βˆ’$112M $159M
Depreciation and amortization $290M $300M $304M $330M
Stock-based compensation $18.0M $22.0M $25.0M $19.0M
Acquisitions $0.0M $0.0M βˆ’$3.0M $0.0M
Share buybacks $0.0M $0.0M $79.0M $115M
Dividends and buybacks $0.0M $0.0M $79.0M $115M
Balance sheet
Cash and short-term investments $176M $223M $141M $120M
Total debt β€” $1.9B $1.9B $1.9B
Finance lease liabilities β€” $34.0M $30.0M $32.0M
Current assets β€” $2.0B $1.8B $2.3B
Current liabilities β€” $1.6B $1.4B $1.8B
Inventory β€” $1.2B $1.2B $1.4B
Property and equipment, net β€” $2.4B $2.4B $2.6B
Goodwill β€” $41.0M $46.0M $47.0M
Intangible assets β€” $104M $97.0M $88.0M
Total assets β€” $4.9B $4.7B $5.4B
Total liabilities β€” $4.2B $4.0B $4.4B
Shareholders' equity $603M $718M $706M $952M
Margins
Net margin 3.6% 1.9% 0.8% 3.2%
FCF margin 0.9% 0.8% βˆ’1.5% 1.9%
Returns
Return on equity 51.1% 23.0% 7.9% 32.9%
Return on assets β€” 3.1% 1.2% 5.4%
Return on tangible equity 51.1% 26.5% 9.9% 33.4%
Growth
Revenue growth β€” βˆ’8.3% βˆ’6.3% 15.2%
Net income growth β€” βˆ’50.6% βˆ’63.2% 387.5%
EPS growth β€” βˆ’51.0% βˆ’63.1% 405.3%
FCF growth β€” βˆ’13.2% βˆ’269.7% β€”
Share count change β€” 1.0% βˆ’0.3% βˆ’4.1%
Financial health
Debt / equity β€” 2.7x 2.7x 2.0x
Current ratio β€” 1.3x 1.3x 1.3x
Quick ratio β€” 0.5x 0.5x 0.5x
Capital allocation
Capex / revenue 3.4% 4.7% 5.6% 3.9%
Stock comp / revenue 0.2% 0.3% 0.3% 0.2%
Payouts / FCF 0.0% 0.0% β€” 72.3%
Quality scores
Piotroski F-score β€” β€” 4.0 8.0
Accruals ratio β€” βˆ’5.7% βˆ’5.1% βˆ’4.3%

Source: SEC EDGAR XBRL filings (CIK 0001563411). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β€” not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move Β· ↡ to open